Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies
The ever-increasing prevalence of noncommunicable diseases (NCDs) represents a major
public health burden worldwide. The most common form of NCD is metabolic diseases …
public health burden worldwide. The most common form of NCD is metabolic diseases …
[HTML][HTML] PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives
Neurodegenerative diseases (NDs) are characteristic with progression of neuron
degeneration, resulting in dysfunction of cognition and mobility. Many neurodegenerative …
degeneration, resulting in dysfunction of cognition and mobility. Many neurodegenerative …
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
J Chotitumnavee, Y Yamashita, Y Takahashi… - Chemical …, 2022 - pubs.rsc.org
We developed a first-in-class proteolysis targeting chimera (PROTAC) for selective
degradation of histone deacetylase 8 (HDAC8). The PROTAC induced degradation of …
degradation of histone deacetylase 8 (HDAC8). The PROTAC induced degradation of …
Targeting undruggable transcription factors with PROTACs: advances and perspectives
Y Li, J Song, P Zhou, J Zhou, S Xie - Journal of Medicinal …, 2022 - ACS Publications
Dysregulation of transcription factors has been implicated in a variety of human diseases.
However, these proteins have traditionally been regarded as undruggable and only a …
However, these proteins have traditionally been regarded as undruggable and only a …
PROTACs: Novel tools for improving immunotherapy in cancer
S Li, T Chen, J Liu, H Zhang, J Li, Z Wang, G Shang - Cancer Letters, 2023 - Elsevier
Posttranslational modifications (PTMs), such as phosphorylation, methylation, ubiquitination,
and acetylation, are important in governing protein expression levels. Proteolysis targeting …
and acetylation, are important in governing protein expression levels. Proteolysis targeting …
TRIM proteins in hepatocellular carcinoma
K Lu, Y Pan, Z Huang, H Liang, Z Ding… - Journal of Biomedical …, 2022 - Springer
The tripartite motif (TRIM) protein family is a highly conserved group of E3 ligases with 77
members known in the human, most of which consist of a RING-finger domain, one or two B …
members known in the human, most of which consist of a RING-finger domain, one or two B …
Ubiquitin–proteasome system as a target for anticancer treatment—an update
YJ Kim, Y Lee, H Shin, SA Hwang, J Park… - Archives of pharmacal …, 2023 - Springer
As the ubiquitin–proteasome system (UPS) regulates almost every biological process, the
dysregulation or aberrant expression of the UPS components causes many pathological …
dysregulation or aberrant expression of the UPS components causes many pathological …
Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications
The success of inhibitor-based therapeutics is largely constrained by the acquisition of
therapeutic resistance, which is partially driven by the undruggable proteome. The …
therapeutic resistance, which is partially driven by the undruggable proteome. The …
Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
Highlights•PROTACs are novel class of molecules efficiently degrades pathogenic
protein.•Due to large hydrophobic structure, PROTACs are usually considered bRo5 …
protein.•Due to large hydrophobic structure, PROTACs are usually considered bRo5 …
Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
The technology known asPROTACs (PROteolysisTArgeting Chimeras) is a method of
protein degradation. Utilising bifunctional small molecules, the ubiquitin-proteosome system …
protein degradation. Utilising bifunctional small molecules, the ubiquitin-proteosome system …